Shrikant Chouhan, Head of Equity Research at Kotak Securities, has recommended buying shares of Emcure Pharmaceuticals and ...
The stock has gained 52.76 per cent over the last six months but remains down 1.84 per cent year-to-date (YTD).
A pharmaceutical stock gained nearly five percent, following news of a strategic acquisition. Investors reacted positively as the company moved to consolidate its stake in a key subsidiary, reflecting ...
Indian frontline indices gained nearly 1% on October 6, with the Nifty 50 closing at 25,077 and the Sensex at 81,709. IT, ...
Bombay Burmah Trading Corporation Ltd clocked volume of 7.18 lakh shares by 14:14 IST on NSE, a 20.24 times surge over two-week average daily volume of 35466 shares ...
The Pioneer on MSN
Trump's 100% tariff on pharma unlikely to have adverse impact on domestic industry: Experts
Indian Pharmaceutical Alliance (IPA), which represents 23 leading Indian pharmaceutical firms, including Dr Reddy's ...
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on ...
US President Donald Trump's recent decision to impose a 100 percent import tariff on branded and patented pharmaceutical ...
CHENNAI: Indian equity markets ended Monday’s session on a strong note, driven by firm gains in banking, healthcare, and information technology stocks. Investor ...
Nifty, Sensex near day’s high. Banking and financial heavyweights post robust quarterly results. Kotak, Axis Bank & HDFC Bank ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback